Abstract
In 2012 CNS & Neurological Disorders - Drug Targets will enter its 11th year of publication. This year will also mark my third year as Editor-in-Chief.
Since taking the helm of the journal a number of changes have been introduced, one of my first having been to renew and expand our Editorial Advisory Board to include a broader base of expertise in this incredibly fast-moving area of science.
Starting last year, and continuing in 2012 CNS & Neurological Disorders - Drug Targets expands its production calendar to 8 issues per year, up from the previous frequency of 6 issues. Other developments, which I believe will strengthen interest in the journal and encourage an increasingly diverse range of topic submissions is the inclusion, apart from reviews, of both full-length and letter-type research articles as well as clinical case reports. We have added also sections dealing with short Research Highlights discussing recent, high impact publications of relevance to the journal's mission together with reports on meetings.
A number of cutting-edge Hot Topic issues are in the works for 2012, including nanoneuroscience, endocannabinoids, novel strategies for neuropsychiatric disorders, and purinergic receptor signaling. CNS & Neurological Disorders - Drug Targets is always open to theme issue proposals from our readers, and I encourage you to submit your ideas for consideration.
With best wishes for a productive New Year,
CNS & Neurological Disorders - Drug Targets
Title:Message from the Editor-in-Chief
Volume: 11 Issue: 1
Author(s): Stephen D. Skaper
Affiliation:
Abstract:
In 2012 CNS & Neurological Disorders - Drug Targets will enter its 11th year of publication. This year will also mark my third year as Editor-in-Chief.
Since taking the helm of the journal a number of changes have been introduced, one of my first having been to renew and expand our Editorial Advisory Board to include a broader base of expertise in this incredibly fast-moving area of science.
Starting last year, and continuing in 2012 CNS & Neurological Disorders - Drug Targets expands its production calendar to 8 issues per year, up from the previous frequency of 6 issues. Other developments, which I believe will strengthen interest in the journal and encourage an increasingly diverse range of topic submissions is the inclusion, apart from reviews, of both full-length and letter-type research articles as well as clinical case reports. We have added also sections dealing with short Research Highlights discussing recent, high impact publications of relevance to the journal's mission together with reports on meetings.
A number of cutting-edge Hot Topic issues are in the works for 2012, including nanoneuroscience, endocannabinoids, novel strategies for neuropsychiatric disorders, and purinergic receptor signaling. CNS & Neurological Disorders - Drug Targets is always open to theme issue proposals from our readers, and I encourage you to submit your ideas for consideration.
With best wishes for a productive New Year,
Export Options
About this article
Cite this article as:
Stephen D. Skaper , Message from the Editor-in-Chief, CNS & Neurological Disorders - Drug Targets 2012; 11 (1) . https://dx.doi.org/10.2174/187152712799960763
DOI https://dx.doi.org/10.2174/187152712799960763 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mediterranean Diet and Longevity
Current Nutrition & Food Science Tachykinins: Role in Human Gastrointestinal Tract Physiology and Pathology
Current Drug Targets Recent Progress in the Medicinal Chemistry of γ-Secretase Inhibitors
Current Topics in Medicinal Chemistry Editorial: Multitarget Molecules for Alzheimer's Disease Therapy
Current Topics in Medicinal Chemistry Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges
Current Diabetes Reviews Management of Inflammatory Bowel Disease Using Stem Cell Therapy
Current Stem Cell Research & Therapy Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer’s Disease?
Current Alzheimer Research Exploring Structural and Physicochemical Profiles of Potential GSK-3β Inhibitors Using Structure- and Ligand-Based Modeling Studies
Combinatorial Chemistry & High Throughput Screening A Review of Pharmacological Properties and Toxicological Effects of Adiantum capillus-veneris L.
Current Drug Discovery Technologies Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration
Current Alzheimer Research Juvenile Delinquency and Challenges of Child and Adolescent Mental Health and Juvenile Justice in Japan
Adolescent Psychiatry <i>LncRNA</i> Xist, X-chromosome Instability and Alzheimer’s Disease
Current Alzheimer Research CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy Islet Amyloid Polypeptide and Diabetes
Current Protein & Peptide Science The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design Delta Opioid Peptides Derived from Plant Proteins
Current Pharmaceutical Design Cyclodextrins as Promoters in Aqueous Organic Synthesis
Current Organic Chemistry